Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BRCA2 anticorps (AA 2308-2537)

BRCA2 Reactivité: Humain WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7433540
  • Antigène Voir toutes BRCA2 Anticorps
    BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
    Épitope
    • 15
    • 12
    • 7
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 2308-2537
    Reactivité
    • 56
    • 23
    • 20
    • 4
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 55
    • 7
    Lapin
    Clonalité
    • 54
    • 8
    Polyclonal
    Conjugué
    • 31
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp BRCA2 est non-conjugé
    Application
    • 37
    • 17
    • 13
    • 13
    • 8
    • 5
    • 5
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Fonction
    Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
    Specificité
    The antibody is a rabbit polyclonal antibody raised against BRCA2. It has been selected for its ability to recognize BRCA2 in immunohistochemical staining and western blotting.
    Purification
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogène
    Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2) corresdonding to Lys2308~His2537 with N-terminal His Tag
    Isotype
    IgG
    Top Product
    Discover our top product BRCA2 Anticorps primaire
  • Indications d'application

    Western blotting: 0.5-2 μg/mL

    1:250-1000 Immunohistochemistry: 5-20 μg/mL

    1:25-100 Immunocytochemistry: 5-20 μg/mL

    1:25-100 Optimal working dilutions must be determined by end user.

    Commentaires

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Date de péremption
    24 months
  • Antigène
    BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
    Autre désignation
    Breast Cancer Susceptibility Protein 2 (BRCA2 Produits)
    Synonymes
    anticorps BRCC2, anticorps BROVCA2, anticorps FACD, anticorps FAD, anticorps FAD1, anticorps FANCB, anticorps FANCD, anticorps FANCD1, anticorps GLM3, anticorps PNCA2, anticorps 30169, anticorps BcDNA:SD25109, anticorps CG13583, anticorps CG13584, anticorps CG30169, anticorps Dmel\\CG30169, anticorps brca2, anticorps dmbrca2, anticorps fancd1, anticorps BRCA2, anticorps brcc2, anticorps brovca2, anticorps facd, anticorps fad, anticorps fad1, anticorps fancb, anticorps AI256696, anticorps AW045498, anticorps Fancd1, anticorps RAB163, anticorps BRCA2, DNA repair associated, anticorps Breast cancer 2, early onset homolog, anticorps breast cancer 2, early onset, anticorps BRCA2, anticorps Brca2, anticorps brca2, anticorps LOC584780
    Sujet
    BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast Cancer 2,Early Onset, Breast Cancer Type 2 Susceptibility Protein, Fanconi anemia group D1 protein
    Pathways
    Réparation de l'ADN, M Phase, Maintenance of Protein Location
Vous êtes ici:
Support technique